SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

Clinical trial NCT06522048 · COMPLETED

Trial details

NCT number: NCT06522048
Sponsor: Chao Ji
Status: COMPLETED
Study type: OBSERVATIONAL

Immune Checkpoint Inhibitor-Induced Dermatitis Stevens-Johnson Syndrome, Drug-Induced Toxic Epidermal Necrolysis Due to Drug

Start date: 2015-01-01
Primary completion: 2024-05-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.